Roble, Belko & Company, Inc Penumbra Inc Transaction History
Roble, Belko & Company, Inc
- $583 Million
- Q1 2024
A detailed history of Roble, Belko & Company, Inc transactions in Penumbra Inc stock. As of the latest transaction made, Roble, Belko & Company, Inc holds 5 shares of PEN stock, worth $879. This represents 0.0% of its overall portfolio holdings.
Number of Shares
5
Previous 5
-0.0%
Holding current value
$879
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PEN
# of Institutions
389Shares Held
27.5MCall Options Held
412KPut Options Held
292K-
Black Rock Inc. New York, NY4.06MShares$715 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA3.69MShares$650 Million0.02% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD3.03MShares$533 Million0.08% of portfolio
-
State Street Corp Boston, MA1.2MShares$212 Million0.01% of portfolio
-
Capital Research Global Investors Los Angeles, CA1.13MShares$199 Million0.06% of portfolio
About Penumbra Inc
- Ticker PEN
- Exchange NYSE
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 37,888,400
- Market Cap $6.67B
- Description
- Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...